The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation
Alexander Hooftman(Trinity College Dublin), Luke O'neill(Trinity College Dublin)
Cited by 571
Related Papers
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
|Cell Research|2015|1.8k
Targeting Toll-like receptors: emerging therapeutics?
|Nature Reviews Drug Discovery|2010|883
Trained immunity, tolerance, priming and differentiation: distinct immunological processes
|Nature Immunology|2020|591
Targeting immunometabolism as an anti-inflammatory strategy
|Cell Research|2020|552
Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer
|Pharmacological Reviews|2009|422